BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 3D Signatures Announces Private Placement With Strategic Partner And Prospectus Update

  October 4, 2017

   · 

  6 min read
• Business

  Avacta Group Preliminary Results for the Year Ending 31 July 2017

  October 4, 2017

   · 

  3 min read
• Biotech Beach

  Applied Spectral Imaging (ASI) Launches Two New Products For The Digital Pathology Market

  October 4, 2017

   · 

  2 min read
• Drug Development

  Adynxx Completes Enrollment In ADYX-004, A Phase II Study Of Brivoligide (AYX1), Lead Compound For The Treatment Of Post-Surgical Pain

  October 4, 2017

   · 

  3 min read
• Business

  K2M President & Chief Executive Officer Eric Major Elected Chairman Of The Board Of Directors

  October 4, 2017

   · 

  8 min read
• Drug Development

  IGC Prepares A Liquid Delivery Formulation Of IGC-AD1 For Alzheimer’s Based On Novel In Vitro Data

  October 4, 2017

   · 

  2 min read
• Business

  The Medicines Patent Pool And Gilead Sign License For Bictegravir

  October 4, 2017

   · 

  3 min read
• Mallinckrodt Discusses Pipeline Transformation, Company Outlook At Investor Briefing

  October 4, 2017

   · 

  6 min read
• Lone Star Bio

  MD Anderson Cancer Center And BridgeBio Launch Navire Pharma To Develop Targeted Therapy For Patients With Difficult-To-Treat Cancer

  BridgeBio has committed $30 million and a team of senior business managers to the company.

  October 4, 2017

   · 

  5 min read
• Drug Development

  Actinium Provides Update On Actimab-A Phase II Clinical Trial For Patients With Acute Myeloid Leukemia

  October 4, 2017

   · 

  3 min read